Skip to main content

Table 2 Adjusted odds of four outcomes in IPF patients (ICD9 516.3 or 515)a

From: Disparities in pulmonary fibrosis care in the United States: an analysis from the Nationwide Inpatient Sample

  Lung Transplant Death Rehabilitation Transfer VATS Biopsy
Odds Ratio (95% CI) P-Value Odds Ratio (95% CI) P-Value Odds Ratio (95% CI) P-Value Odds Ratio (95% CI) P-Value
Insurance
 Non-medicaid Reference Reference   Reference   Reference  
 Medicaid 0.30 (0.16, 0.57) < 0.001 1.00 (0.89, 1.12) 0.95 0.53 (0.33, 0.85) 0.01 0.46 (0.35, 0.60) < 0.001
 Uninsured 0.22 (0.07, 0.72) 0.01 1.12 (0.92, 1.35) 0.26 0.41 (0.18, 0.93) 0.03 0.52 (0.35, 0.77) < 0.01
ZIP Income Quartile
 Quartile 1 0.46 (0.32, 0.66) < 0.001 0.93 (0.87, 1.00) 0.04 1.16 (0.92, 1.45) 0.21 1.01 (0.81, 1.25) 0.96
 Quartile 2 0.56 (0.43, 0.73) < 0.001 0.91 (0.85, 0.97) < 0.01 1.00 (0.80, 1.24) 0.97 1.09 (0.90, 1.33) 0.38
 Quartile 3 0.71 (0.57, 0.89) < 0.01 0.96 (0.90, 1.02) 0.19 1.11 (0.90, 1.36) 0.33 0.98 (0.81, 1.18) 0.81
 Quartile 4 (Highest) Reference   Reference   Reference   Reference  
  1. aAnalyses of death, rehab, and VATS were adjusted for age, race, gender, insurance, year, zip income quartile, hospital region, hospital location, hospital teaching status, hospital bedsize, and AHRQ Elixhauser Comorbidity index for in-hospital mortality. Analyses of lung transplantation were adjusted for these same variables, but not hospital teaching status nor urban/rural location, because the proportion of lung transplantations exhibiting these characteristics was either 0% or 100%